Amylyx Pharmaceuticals, Inc. Common Stock
Symbol: AMLX (NASDAQ)
Company Description:
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
- Today's Open: $15.25
- Today's High: $15.435
- Today's Low: $15.25
- Today's Volume: 30
- Yesterday Close: $15.37
- Yesterday High: $15.405
- Yesterday Low: $14.67
- Yesterday Volume: 1.62M
- Last Min Volume: 10
- Last Min High: $15.435
- Last Min Low: $15.435
- Last Min VWAP: $15.435
- Name: Amylyx Pharmaceuticals, Inc. Common Stock
- Website: https://www.amylyx.com
- Listed Date: 2022-01-07
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001658551
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.64B
- Round Lot: 100
- Outstanding Shares: 106.67M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-10-07 | SCHEDULE 13G | View |
2025-10-02 | 4 | View |
2025-10-02 | 4 | View |
2025-10-02 | 4 | View |
2025-10-02 | 4 | View |
2025-10-02 | 4 | View |
2025-09-10 | 8-K | View |
2025-09-10 | 424B5 | View |
2025-09-09 | 424B5 | View |
2025-08-27 | 8-K | View |
2025-08-14 | 4 | View |
2025-08-12 | 144 | View |
2025-08-12 | SCHEDULE 13G/A | View |
2025-08-07 | 10-Q | View |
2025-08-07 | 8-K | View |
2025-07-29 | SCHEDULE 13G | View |
2025-07-17 | SCHEDULE 13G | View |
2025-06-25 | SCHEDULE 13G | View |
2025-06-09 | 4 | View |
2025-06-09 | 4 | View |